Back to Journals » Biologics: Targets and Therapy
Biologics: Targets and Therapy
Editor-in-Chief: Professor Shein-Chung Chow
ISSN: 1177-5475 (Print) - went to online only in 2009
An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (605)
- Volume 20, 2026 (18)
- Volume 19, 2025 (56)
- Volume 18, 2024 (35)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Latest articles:
- 5 records -
Vunakizumab for IL-17A–Mediated Diseases: A Review in Psoriasis and Spondyloarthritis
Yan H, Chen Y, Song Y, Yan M, Yan K
Biologics: Targets and Therapy 2026, 20:500475
Published Date: 8 June 2026
Immunological Biomarkers in Glioblastoma: Targeting T and NK Cells for Enhanced Diagnosis and Prognosis
Akbari AM, Bourbour S, Seyedmehdi MS, Shiari S, Rustamzadeh A, Seif F, Farivar S
Biologics: Targets and Therapy 2026, 20:603545
Published Date: 29 May 2026
MicroRNA-661 Suppresses Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells and Endothelial Cells by Targeting CCND2
Jiang L, Yang A, Liu J, Zhou J
Biologics: Targets and Therapy 2026, 20:592879
Published Date: 28 May 2026
Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review
Deng S, Jiang Y, Li W, Shu Z, Chen T, Liang J, Zhang X
Biologics: Targets and Therapy 2026, 20:592069
Published Date: 22 May 2026
Rapid Resolution of Psoriasis Following Low-Dose Interleukin-2 Monotherapy: A Case Report
Ma D, Li Z
Biologics: Targets and Therapy 2026, 20:595201
Published Date: 20 May 2026